Condyloma acuminatum
Conditions
Interventions
Trial group:Wei Ren Anti-Wart Formula topical application
Control group:Placebo topical application
Sponsors
Yueyang Hospital of Integrative Medicine, Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: I. clinical diagnosis of condyloma acuminatum, between the ages of 18 and 65 years;,both sexes II. warts located in the perianal area, distal urethra and external genitalia. III. Patients were unsuitable for surgery for various reasons, unwilling to undergo surgery and volunteered to participate despite being informed of other alternatives, and were willing to pay for the treatment and agreed to have their skin lesions photographed. IV. who voluntarily participated in this study and signed the informed consent form.
Exclusion criteria
Exclusion criteria: I. clinical diagnosis of CA, between 18 and 65 years of age ; both sexes. II. warts located in the perianal area, distal urethra and external genitalia. III. Patients were unsuitable for surgery for various reasons, unwilling to undergo surgery and volunteered to participate despite being informed of other alternatives, and were willing to pay for the treatment and agreed to have their lesions photographed. IV. who voluntarily participated in this study and signed the informed consent form. Exclusion criteria I. Those who have undergone ALA-PDT treatment within 12 weeks and those who apply any other treatment that affects the study. II. Those with a combination of other conditions that may affect the evaluation of efficacy, such as other photodermatological conditions. III. those who have taken phototoxic or photosensitizing drugs within 12 weeks IV. clinical and/or pathological evidence of tumor invasion to other organs or tissues. V. Severely immunocompromised individuals. VI. Scarred individuals. VII. Those with known cutaneous photosensitivity, porphyria or allergy to ALA, light or lidocaine VIII. Those with severe medical, psychological and psychiatric illnesses, infectious diseases, or pregnant or lactating women. IX. Any other reason deemed by the investigator to be inappropriate for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| time to recurrence; | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS;infection;Incidence of superficial scarring; | — |
Countries
China
Contacts
Public ContactHUA LIANG
Yueyang Hospital of Integrative Medicine, Shanghai University of Traditional Chinese Medicine
Outcome results
None listed